SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-030629
Filing Date
2024-04-05
Accepted
2024-04-05 08:51:05
Documents
15
Period of Report
2024-04-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0203310-8k_golden.htm   iXBRL 8-K 47560
2 PROMISSORY NOTE, DATED APRIL 3, 2024, ISSUED BY GOLDEN ARROW MERGER CORP. TO GOL ea020331002ex10-1_golden.htm EX-10.1 23422
  Complete submission text file 0001213900-24-030629.txt   308319

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gamc-20240403.xsd EX-101.SCH 4209
4 XBRL DEFINITION FILE gamc-20240403_def.xml EX-101.DEF 27337
5 XBRL LABEL FILE gamc-20240403_lab.xml EX-101.LAB 37938
6 XBRL PRESENTATION FILE gamc-20240403_pre.xml EX-101.PRE 25957
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0203310-8k_golden_htm.xml XML 7343
Mailing Address 10 E. 53RD STREET 13TH FLOOR NEW YORK NY 10022
Business Address 10 E. 53RD STREET 13TH FLOOR NEW YORK NY 10022 212-430-2214
Golden Arrow Merger Corp. (Filer) CIK: 0001841125 (see all company filings)

IRS No.: 861256660 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40223 | Film No.: 24824873
SIC: 2860 Industrial Organic Chemicals
(CF Office: 03 Life Sciences)